182 related articles for article (PubMed ID: 16566890)
1. Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis.
Kato Z; Asano T; Kondo N
J Child Neurol; 2006 Feb; 21(2):177-8. PubMed ID: 16566890
[TBL] [Abstract][Full Text] [Related]
2. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
Gascon GG;
J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
[TBL] [Abstract][Full Text] [Related]
3. Inosiplex in the treatment of subacute sclerosing panencephalitis.
Silverberg R; Brenner T; Abramsky O
Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
[TBL] [Abstract][Full Text] [Related]
4. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
[TBL] [Abstract][Full Text] [Related]
5. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis.
Anlar B; Yalaz K; Köse G; Saygi S
J Child Neurol; 1998 Nov; 13(11):557-9. PubMed ID: 9853649
[TBL] [Abstract][Full Text] [Related]
6. Subacute sclerosing panencephalitis with fulminating course: follow-up magnetic resonance spectroscopy (MRS) findings.
Alkan A; Kutlu R; Sigirci A; Aslan M; Sarac K; Yakinci C
J Child Neurol; 2004 Mar; 19(3):233-8. PubMed ID: 15119488
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
Dyken PR; Swift A; DuRant RH
Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
[TBL] [Abstract][Full Text] [Related]
8. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
Anlar B
Neurology; 2007 Apr; 68(17):1438; author reply 1438. PubMed ID: 17452596
[No Abstract] [Full Text] [Related]
9. Adult-onset subacute sclerosing panencephalitis first seen as craniocervical myoclonus.
Vela L; Garcia-Merino A; Escamilla C
Mov Disord; 1997 May; 12(3):462-4. PubMed ID: 9159751
[No Abstract] [Full Text] [Related]
10. Serial proton spectroscopy in a case of adult-onset subacute sclerosing panencephalitis.
Michael N; Erfurth A; Lüdemann P; Schuierer G; Möller HE
Psychiatry Res; 2005 Aug; 139(3):269-73. PubMed ID: 16051471
[TBL] [Abstract][Full Text] [Related]
11. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
Aydin K; Tatli B; Ozkan M; Ciftci K; Unal Z; Sani S; Ozmen M; Caliskan M; Aydinli N; Guven S
Neurology; 2006 Sep; 67(5):911-3. PubMed ID: 16966569
[TBL] [Abstract][Full Text] [Related]
12. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
DuRant RH; Dyken PR
Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
[TBL] [Abstract][Full Text] [Related]
13. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
DuRant RH; Dyken PR; Swift AV
J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
[TBL] [Abstract][Full Text] [Related]
14. Treatment of subacute sclerosing panencephalitis: an overview.
Taylor WJ; DuRant RH; Dyken PR
Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
[TBL] [Abstract][Full Text] [Related]
15. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.
Anlar B; Yalaz K; Imir T; Turanli G
Eur Neurol; 1994; 34(1):44-7. PubMed ID: 7511102
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
[TBL] [Abstract][Full Text] [Related]
17. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
Noetzel MJ; Dodson WE
Ann Neurol; 1983 Apr; 13(4):457-60. PubMed ID: 6188412
[TBL] [Abstract][Full Text] [Related]
18. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
[No Abstract] [Full Text] [Related]
19. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
[TBL] [Abstract][Full Text] [Related]
20. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
